United Capital Financial Advisers, LLC Cns Pharmaceuticals, Inc. Transaction History

United Capital Financial Advisers, LLC

  • $11.5 Billion
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
BUY
$0.26 - $0.43 $4,925 - $8,145
18,944 New
18,944 $5,000

Others Institutions Holding CNSP

# of Institutions
1
Shares Held
100
Call Options Held
0
Put Options Held
0
View Full List

About CNS Pharmaceuticals, Inc.

CNSP Quotes by TradingView
  • Ticker CNSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,032,500
  • Market Cap $4.4M
  • Description
  • CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme....
More about CNSP
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email